2 months ago
AXSM
AnalystsAshwani VermaAshwani Verma's Stock Forecasts
AnalystsAshwani Verma
Analyst Ranking
Top 16%
#840 out of 5220 analysts
Average Return
+9.55%
Win Rate
49%41 out of 84
Risk vs Reward
Poor
Good
Ashwani Verma's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcellx IncACLX | +164.51% | $35.16 | $93.00 | 2023-10-17 - 2024-10-16 | Strong Buy |
Avadel Pharmaceuticals PLCAVDL | +137.72% | $7.82 | $18.59 | 2025-01-13 - 2025-10-28 | Strong Buy |
Cytokinetics IncCYTK | +116.84% | $37.71 | $81.77 | 2023-04-03 - 2024-01-24 | Strong Buy |
United Therapeutics CorpUTHR | +87.93% | $287.35 | $540.02 | 2025-06-30 - 2026-03-17 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +85.37% | $17.84 | $33.07 | 2025-01-30 - 2026-01-29 | Strong Buy |
Ashwani Verma Analyst Color
Get additional color on Ashwani Verma's coverage of popular stocks
4 months ago
JAZZ
4 months ago
ABBV
5 months ago
NBIX
6 months ago
TEVA
2 years ago
TEVA
2 years ago
LEGN
2 years ago
ITCI
Ashwani Verma's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cytokinetics IncCYTK | 6 | Hold | $69.00 | +11.06% | Maintains | 12 days ago |
United Therapeutics CorpUTHR | 12 | Strong Buy | $705.00 | +30.55% | Maintains | 13 days ago |
Axsome Therapeutics IncAXSM | 7 | Strong Buy | $251.00 | +55.74% | Maintains | 22 days ago |
Harmony Biosciences Holdings IncHRMY | 4 | Hold | $46.00 | +62.14% | Downgrades | a month ago |
Neurocrine Biosciences IncNBIX | 11 | Strong Buy | $178.00 | +36.18% | Maintains | 2 months ago |
Insmed IncINSM | 1 | Strong Buy | $215.00 | +49.38% | Maintains | 2 months ago |
Acadia Pharmaceuticals IncACAD | 9 | Strong Buy | $40.00 | +91.39% | Maintains | 2 months ago |
Corcept Therapeutics IncCORT | 1 | Hold | $95.00 | +183.50% | Initiates Coverage On | 3 months ago |
Legend Biotech CorpLEGN | 4 | Strong Buy | $48.00 | +158.76% | Maintains | 3 months ago |
Biohaven LtdBHVN | 5 | Hold | $11.00 | +15.42% | Downgrades | 4 months ago |
Jazz Pharmaceuticals PLCJAZZ | 7 | Hold | $188.00 | +3.66% | Downgrades | 4 months ago |
AlvotechALVO | 1 | Strong Buy | $10.00 | +161.78% | Maintains | 4 months ago |
Abbvie IncABBV | 1 | Hold | $220.00 | +0.11% | Maintains | 4 months ago |
Exelixis IncEXEL | 5 | Hold | $40.00 | -4.37% | Maintains | 4 months ago |
Avadel Pharmaceuticals PLCAVDL | 4 | Hold | $20.00 | -7.58% | Downgrades | 5 months ago |
Teva Pharmaceutical Industries LtdTEVA | 10 | Strong Buy | $26.00 | -13.59% | Maintains | 6 months ago |
Incyte CorpINCY | 2 | Hold | $68.00 | -27.83% | Maintains | 8 months ago |
Immunovant IncIMVT | 1 | Hold | $18.00 | -28.29% | Maintains | 8 months ago |
Alkermes PLCALKS | 4 | Strong Buy | $42.00 | +51.90% | Upgrades | 9 months ago |
Coherus Oncology IncCHRS | 5 | Hold | $1.05 | -37.50% | Maintains | a year ago |
Arcellx IncACLX | 2 | Strong Buy | $114.00 | N/A | Maintains | a year ago |
Intra Cellular Therapies IncITCI | 5 | Hold | $79.00 | N/A | Maintains | 2 years ago |
Royalty Pharma PLCRPRX | 3 | Hold | $28.00 | N/A | Downgrades | 2 years ago |
Coherent CorpCOHR | 1 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 2 | Hold | $209.00 | N/A | Initiates Coverage On | 3 years ago |
Viatris IncVTRS | 2 | Hold | $12.00 | N/A | Upgrades | 3 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Hold | $71.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.